Artesunate versus quinine in the treatment of severe imported malaria: Comparative analysis of adverse events focussing on delayed haemolysis

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Rolling, Thierry ^a,b   Wichmann, Dominic ^a   Schmiedel, Stefan ^a   Burchard, Gerd D ^a,b   Kluge, Stefan ^a   Cramer, Jakob P ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Adverse events; Artesunate; Haemolysis; Imported malaria; Quinine; Severe malaria

Indexed keywords

ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; DOXYCYCLINE; QUININE;

ADULT; ARTICLE; CARDIOTOXICITY; CLINICAL ARTICLE; COMPARATIVE STUDY; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEARING DISORDER; HEMOLYSIS; HUMAN; HYPOGLYCEMIA; INAPPROPRIATE VASOPRESSIN SECRETION; KIDNEY FUNCTION; LIVER FUNCTION TEST; MALARIA; MALE; MEDICAL RECORD REVIEW; PNEUMONIA; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; ANEMIA, HEMOLYTIC; ANTIMALARIALS; ARTEMISININS; DRUG TOXICITY; FEMALE; GERMANY; HUMAN MIGRATION; HUMANS; MALARIA; MALE; MIDDLE AGED; QUININE; RETROSPECTIVE STUDIES;

EID: 84880124567     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-241     Document Type: Article

References (33)

1. Centralized information system for infectious dieases (CISID) http://data.euro.who.int/cisid
2. Infektionepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2011 Berlin, Germany, Robert-Koch-Institut, 2012
3. Management of imported malaria in Europe. Askling H, Bruneel F, Burchard G, Castelli F, Chiodini P, Grobusch M, Lopez-Velez R, Paul M, Petersen E, Popescu C, Ramharter M, Schlagenhauf P, European Society for Clinical Microbiology and Infectious Diseases Study Group on Clinical Parasitology, Malar J 2012 11 328 10.1186/1475-2875-11-328 22985344
4. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Dondorp A, Nosten F, Stepniewska K, Day N, White N, Lancet 2005 366 717 725 16125588 (Pubitemid 41207233)
5. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NP, White NJ, AQUAMAT group, Lancet 2010 376 1647 1657 10.1016/S0140-6736(10)61924-1 21062666
6. Artesunate versus quinine for treating severe malaria. Sinclair D, Donegan S, Isba R, Lalloo DG, Cochrane Database Syst Rev 2012 6 CD005967
7. Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre. Eder M, Farne H, Cargill T, Abbara A, Davidson RN, Pathog Glob Health 2012 106 181 187 10.1179/2047773212Y.0000000032 23265377
8. Leitlinie, Diagnostik und Therapie der Malaria http://www.awmf.org/ uploads/tx-szleitlinien/042-001l-S1-Malaria-2013-01.pdf
9. WHO, Guidelines for the treatment of malaria Geneva, Switzerland: World Health Organization, WHO, 2 2010
10. Treatment of imported severe malaria with artesunate instead of quinine-more evidence needed? Cramer JP, Lopez-Velez R, Burchard GD, Grobusch MP, de Vries PJ, Malar J 2011 10 256 10.1186/1475-2875-10-256 21899729
11. Cinchonism: two case reports and review of acute quinine toxicity and treatment. Wolf LR, Otten EJ, Spadafora MP, J Emerg Med 1992 10 295 301 10.1016/0736-4679(92)90336-R 1624742
12. Antimalarial drug toxicity: a review. AlKadi HO, Chemotherapy 2007 53 385 391 10.1159/000109767 17934257 (Pubitemid 350085250)
13. Severe malaria, artesunate and haemolysis. Caramello P, Balbiano R, De Blasi T, Chiriotto M, Deagostini M, Calleri G, J Antimicrob Chemother 2012 67 2053 2054 10.1093/jac/dks139 22523307
14. Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium. Kreeftmeijer-Vegter AR, van Genderen PJ, Visser LG, Bierman WF, Clerinx J, van Veldhuizen CK, de Vries PJ, Malar J 2012 11 102 10.1186/1475-2875-11-102 22462806
15. Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia. Rolling T, Schmiedel S, Wichmann D, Wittkopf D, Burchard GD, Cramer JP, Malar J 2012 11 169 10.1186/1475-2875-11-169 22594446
16. Intravenous artesunate for severe malaria in travelers, Europe. Zoller T, Junghanss T, Kapaun A, Gjorup I, Richter J, Hugo-Persson M, Morch K, Foroutan B, Suttorp N, Yurek S, Flick H, Emerg Infect Dis 2011 17 771 777 10.3201/eid1705.101229 21529383
17. Rare disease (orphan) designations http://www.ema.europa.eu/docs/en-GB/ document-library/Brochure/2011/03/WC500104234.pdf
18. ATU nominative, protocole d'utilisation thérapeutique et de recueil d'informations, Malacef® (artésunate) 60mg, poudre et solvant pour solution injectable http://www.ansm.sante.fr/Activites/Autorisations- Temporairesd-Utilisation-ATU/Protocoles-d-utilisation-therapeutique/ Liste-des-specialites-soumises-a-un-protocole-dutilisation-therapeutique/ MALACEF-60-mg-poudre-et-solvant-pour-solution-injectable/(language)/fre-FR
19. Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria-worldwide, 2010-2012. Centres for Disease C, Prevention, MMWR Morb Mortal Wkly Rep 2013 62 5 8 23302816
20. In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria. Angus BJ, Chotivanich K, Udomsangpetch R, White NJ, Blood 1997 90 2037 2040 9292540 (Pubitemid 27377317)
21. The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria. Chotivanich K, Udomsangpetch R, Dondorp A, Williams T, Angus B, Simpson JA, Pukrittayakamee S, Looareesuwan S, Newbold CI, White NJ, J Infect Dis 2000 182 629 633 10.1086/315718 10915102 (Pubitemid 30651065)
22. Renal failure in malaria. Das BS, J Vector Borne Dis 2008 45 83 97 18592837 (Pubitemid 351809284)
23. Effects of sodium artesunate, a new antimalarial drug, on renal function. Campos SB, Rouch LHK, Seguro AC, Kidney Int 2001 59 1044 1051 10.1046/j.1523-1755.2001.0590031044.x 11231359 (Pubitemid 32208273)
24. Diuretic effect of sodium artesunate in patients with malaria. Seguro AC, Campos SB, AmJTrop Med Hyg 2002 67 473 474 (Pubitemid 35403160)
25. Cardiotoxicity of antimalarial drugs. White NJ, Lancet Infect Dis 2007 7 549 10.1016/S1473-3099(07)70187-1 17646028 (Pubitemid 47077715)
26. Evaluation of the patient with hyponatremia. Sterns RH, Waltham, MA: UpToDate, Basow DF, Waltham MA, 2013
27. Clinical practice. The syndrome of inappropriate antidiuresis. Ellison DH, Berl T, N Engl J Med 2007 356 2064 2072 10.1056/NEJMcp066837 17507705 (Pubitemid 46789896)
28. Hyponatraemia in imported malaria: the pathophysiological role of vasopressin. Hoorn EJ, van Wolfswinkel ME, Hesselink DA, de Rijke YB, Koelewijn R, van Hellemond JJ, van Genderen PJJ, Malar J 2012 11 26 10.1186/1475-2875-11- 26 22280539
29. Inappropriate secretion of antidiuretic hormone and hyponatremia in severe falciparum malaria. Holst FG, Hemmer CJ, Kern P, Dietrich M, AmJTrop Med Hyg 1994 50 602 607 (Pubitemid 24196350)
30. Eosinophilic pneumonias. Akuthota P, Weller PF, Clin Microbiol Rev 2012 25 649 660 10.1128/CMR.00025-12 23034324
31. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Solomon J, Schwarz M, Semin Respir Crit Care Med 2006 27 192 197 10.1055/s-2006-939522 16612770
32. Clinical evaluation of 12 cases of antimicrobial drug-induced pneumonitis. Kohno S, Yamaguchi K, Yasuoka A, Koga H, Hayashi T, Komori K, Hara K, Jpn J Med 1990 29 248 254 10.2169/internalmedicine1962.29.248 2273603 (Pubitemid 20338908)
33. Pneumotox v2.0 http://www.pneumotox.com